Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation

Toxicology Letters

Volumn 214, Issue 3, 2012, Pages 288-295

  Kanthasamy, A G ^a   Choi, C ^a   Jin, H ^a   Harischandra, D S ^a   Anantharam, V ^a   Kanthasamy, A ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Manganese; Metals; Neurotoxicity; Proteasome dysfunction; Protein aggregation

Indexed keywords

CADMIUM; MANGANESE; OLIGOMER; PRION PROTEIN; PROTEINASE K;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STEM CELL; UBIQUITINATION;

ANIMALS; CADMIUM CHLORIDE; CELL SURVIVAL; CELLS, CULTURED; CHLORIDES; MANGANESE COMPOUNDS; MICE; NEURONS; PRIONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN MULTIMERIZATION; UBIQUITINATION;

EID: 84867235684     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.09.008     Document Type: Article

References (50)

1. Aguzzi A., Steele A.D. Prion topology and toxicity. Cell 2009, 137:994-996.
2. Anantharam V., Kanthasamy A., Choi C.J., Martin D.P., Latchoumycandane C., Richt J.A., Kanthasamy A.G. Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radical Biology & Medicine 2008, 45:1530-1541.
3. Brazier M.W., Davies P., Player E., Marken F., Viles J.H., Brown D.R. Manganese binding to the prion protein. Journal of Biological Chemistry 2008, 283:12831-12839.
4. Brown D.R. Role of the prion protein in copper turnover in astrocytes. Neurobiology of Disease 2004, 15:534-543.
5. Brown D.R., Hafiz F., Glasssmith L.L., Wong B.S., Jones I.M., Clive C., Haswell S.J. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO Journal 2000, 19:1180-1186.
6. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., Fraser P.E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., Kretzschmar H. The cellular prion protein binds copper in vivo. Nature 1997, 390:684-687.
7. Chen S., Xu Y., Xu B., Guo M., Zhang Z., Liu L., Ma H., Chen Z., Luo Y., Huang S., Chen L. CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death. Journal of Neurochemistry 2011, 119:1108-1118.
8. Chesebro B., Wehrly K., Caughey B., Nishio J., Ernst D., Race R. Foreign PrP expression and scrapie infection in tissue culture cell lines. Developments in Biological Standardization 1993, 80:131-140.
9. Choi C.J., Anantharam V., Martin D.P., Nicholson E.M., Richt J.A., Kanthasamy A., Kanthasamy A.G. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicological Sciences: an Official Journal of the Society of Toxicology 2010, 115:535-546.
10. Choi C.J., Anantharam V., Saetveit N.J., Houk R.S., Kanthasamy A., Kanthasamy A.G. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicological Sciences: an Official Journal of the Society of Toxicology 2007, 98:495-509.
11. Ciechanover A., Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003, 40:427-446.
12. Cohen E., Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO Journal 2003, 22:404-417.
13. Di Natale G., Grasso G., Impellizzeri G., La Mendola D., Micera G., Mihala N., Nagy Z., Osz K., Pappalardo G., Rigo V., Rizzarelli E., Sanna D., Sovago I. Copper(II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability, and binding details of copper(II) complexes with PrP 106-126 peptides. Inorganic Chemistry 2005, 44:7214-7225.
14. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Annals of the New York Academy of Sciences 2004, 1012:115-128.
15. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., Chiesa R. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. Journal of Biological Chemistry 2005, 280:11320-11328.
16. Gaggelli E., Bernardi F., Molteni E., Pogni R., Valensin D., Valensin G., Remelli M., Luczkowski M., Kozlowski H. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies. Journal of the American Chemical Society 2005, 127:996-1006.
17. Hesketh S., Sassoon J., Knight R., Brown D.R. Elevated manganese levels in blood and CNS in human prion disease. Molecular and Cellular Neurosciences 2008, 37:590-598.
18. Hesketh S., Sassoon J., Knight R., Hopkins J., Brown D.R. Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy. Journal of Animal Science 2007, 85:1596-1609.
19. Hilker R., Brotchie J.M., Chapman J. Pros and cons of a prion-like pathogenesis in Parkinson's disease. BMC Neurology 2011, 11:74.
20. Jackson G.S., Murray I., Hosszu L.L., Gibbs N., Waltho J.P., Clarke A.R., Collinge J. Location and properties of metal-binding sites on the human prion protein. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:8531-8535.
21. Kang S.C., Brown D.R., Whiteman M., Li R., Pan T., Perry G., Wisniewski T., Sy M.S., Wong B.S. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. Journal of Pathology 2004, 203:603-608.
22. Kaul S., Anantharam V., Kanthasamy A., Kanthasamy A.G. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death. Brain Research. Molecular Brain Research 2005, 139:137-152.
23. Kristiansen M., Messenger M.J., Klohn P.C., Brandner S., Wadsworth J.D., Collinge J., Tabrizi S.J. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. Journal of Biological Chemistry 2005, 280:38851-38861.
24. Lehman N.L. The ubiquitin proteasome system in neuropathology. Acta Neuropathologica 2009, 118:329-347.
25. Lopez E., Arce C., Oset-Gasque M.J., Canadas S., Gonzalez M.P. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radical Biology & Medicine 2006, 40:940-951.
26. Ma J., Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:14955-14960.
27. Martin D.P., Anantharam V., Jin H., Witte T., Houk R., Kanthasamy A., Kanthasamy A.G. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology 2011, 32:554-562.
28. Mayer R.J. From neurodegeneration to neurohomeostasis: the role of ubiquitin. Drug News & Perspectives 2003, 16:103-108.
29. Minami A., Takeda A., Nishibaba D., Takefuta S., Oku N. Cadmium toxicity in synaptic neurotransmission in the brain. Brain Research 2001, 894:336-339.
30. Narita K., Kawasaki F., Kita H. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Research 1990, 510:289-295.
31. Nishina K., Jenks S., Supattapone S. Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity. Journal of Biological Chemistry 2004, 279:40788-40794.
32. Olanow C.W., McNaught K. Parkinson's disease, proteins, and prions: Milestones. Movement Disorders: Official Journal of the Movement Disorder Society 2011, 26:1056-1071.
33. Prinz M., Heikenwalder M., Junt T., Schwarz P., Glatzel M., Heppner F.L., Fu Y.X., Lipp M., Aguzzi A. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 2003, 425:957-962.
34. Priola S.A., Caughey B., Raymond G.J., Chesebro B. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infectious Agents and Disease 1994, 3:54-58.
35. Pushie M.J., Pickering I.J., Martin G.R., Tsutsui S., Jirik F.R., George G.N. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics: Integrated Biometal Science 2011, 3:206-214.
36. Raeber A.J., Race R.E., Brandner S., Priola S.A., Sailer A., Bessen R.A., Mucke L., Manson J., Aguzzi A., Oldstone M.B., Weissmann C., Chesebro B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO Journal 1997, 16:6057-6065.
37. Singh A., Isaac A.O., Luo X., Mohan M.L., Cohen M.L., Chen F., Kong Q., Bartz J., Singh N. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathogens 2009, 5:e1000336.
38. Stanczak P., Valensin D., Juszczyk P., Grzonka Z., Migliorini C., Molteni E., Valensin G., Gaggelli E., Kozlowski H. Structure and stability of the Cu(II) complexes with tandem repeats of the chicken prion. Biochemistry 2005, 44:12940-12954.
39. Stohr J., Weinmann N., Wille H., Kaimann T., Nagel-Steger L., Birkmann E., Panza G., Prusiner S.B., Eigen M., Riesner D. Mechanisms of prion protein assembly into amyloid. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2409-2414.
40. Sun F., Anantharam V., Latchoumycandane C., Kanthasamy A., Kanthasamy A.G. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. Journal of Pharmacology and Experimental Therapeutics 2005, 315:69-79.
41. Takemura K., Wang P., Vorberg I., Surewicz W., Priola S.A., Kanthasamy A., Pottathil R., Chen S.G., Sreevatsan S. DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Experimental Biology and Medicine (Maywood, NJ) 2006, 231:204-214.
42. Tenzer S., Stoltze L., Schonfisch B., Dengjel J., Muller M., Stevanovic S., Rammensee H.G., Schild H. Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility. Journal of Immunology 2004, 172:1083-1091.
43. Thackray A.M., Knight R., Haswell S.J., Bujdoso R., Brown D.R. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochemical Journal 2002, 362:253-258.
44. Treiber C., Simons A., Multhaup G. Effect of copper and manganese on the de novo generation of protease-resistant prion protein in yeast cells. Biochemistry 2006, 45:6674-6680.
45. Usai C., Barberis A., Moccagatta L., Marchetti C. Pathways of cadmium influx in mammalian neurons. Journal of Neurochemistry 1999, 72:2154-2161.
46. Varela-Nallar L., Toledo E.M., Larrondo L.F., Cabral A.L., Martins V.R., Inestrosa N.C. Induction of cellular prion protein gene expression by copper in neurons. American Journal of Physiology Cell physiology 2006, 290:C271-C281.
47. Wong B.S., Chen S.G., Colucci M., Xie Z., Pan T., Liu T., Li R., Gambetti P., Sy M.S., Brown D.R. Aberrant metal binding by prion protein in human prion disease. Journal of Neurochemistry 2001, 78:1400-1408.
48. Wong E., Thackray A.M., Bujdoso R. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. Biochemical Journal 2004, 380:273-282.
49. Xu B., Chen S., Luo Y., Chen Z., Liu L., Zhou H., Chen W., Shen T., Han X., Chen L., Huang S. Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network. PloS ONE 2011, 6:e19052.
50. Yedidia Y., Horonchik L., Tzaban S., Yanai A., Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO Journal 2001, 20:5383-5391.